PSEN1 and Alzheimer disease: The promising effects of MR-39 on cell viability and cytokine profiles in OHCs suggested an investigation of possible functional relevance of MR-39 in AD, which was assessed by chronic administration of the compound to double-transgenic APP/PS1 mice.